3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Peutz-Jeghers Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Hereditary pancreatitis
1
Hereditary Sensory and Autonomic Neuropathies
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Breast Neoplasms
1
Interventions
Fulvestrant
4
serabelisib
2
sapanisertib
2
ribociclib
2
palbociclib
2
tivozanib
1
pembrolizumab
1
olaparib
1
exemestane
1
abemaciclib
1
Tamoxifen
1
Secretin
1
STX-478
1
Radiotherapy
1
Pharmaceutical Preparations
1
Paclitaxel
1
Nivolumab
1
Metformin
1
Letrozole
1
Irinotecan
1
Imlunestrant
1
Gemcitabine
1
Carboplatin
1
CA-19-9 Antigen
1
Anastrozole
1
AZD1390
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Hereditary Sensory and Autonomic Neuropathies
×
CA-19-9 Antigen
×
Clear all
NCT02000089
2025-10-09
CAPS5
Johns Hopkins University
Phase 3
Recruiting
9,000 enrolled